Gout Flare Risk and Effect of Colchicine Prophylaxis on Flares After COVID-19 Vaccination
Researchers determined risk for gout flares and the effect of colchicine prophylaxis on flares following COVID-19 vaccination.
All articles by Bradley van Paridon
Safety, Efficacy of Aminoglycosides or Polymyxin Monotherapy for Complicated UTI
Researchers conducted a study to assess the safety and efficacy of aminoglycosides or polymyxin monotherapy for the treatment of adults with complicated urinary tract infections caused by extensively drug-resistant Pseudomonas aeruginosa.
N95 Respirators vs Surgical Masks for Protection Against Viral Respiratory Illnesses
Researchers conducted a meta-analysis to determine the effectiveness of N95 respirators vs surgical masks in protecting against viral respiratory illness transmission.
No Difference Between Early and Late Allopurinol Initiation for Acute Gout Flare
Researchers compared the time to complete resolution of acute gout flare between early and late allopurinol initiation.
Effect of Probenecid on Cephalexin Pharmacokinetics and Pharmacodynamics
Researchers conducted a crossover study to determine whether probenecid and cephalexin administered together increases the clinical benefits of cephalexin.
Frequency, Variety, and Severity of Persistent COVID-19 Symptoms
Researchers systematically reviewed studies to gauge the frequency, variety, and severity of persistent symptoms after COVID-19 infection.
Study Evaluates Characteristics, Comorbidities, and Kidney Function of Patients With Uncontrolled Gout Receiving Pegloticase
In this study presented at the EULAR 2021 Virtual Congress, researchers examined the demographics and comorbidities of patients with uncontrolled gout receiving pegloticase.
Safety and Efficacy Data of Gout Flare Prophylaxis Analyzed in Patients With Chronic Kidney Disease
The review was aimed at describing the current literature on the efficacy and safety of gout flare prophylaxis and therapy in patients with chronic kidney disease.
Proinflammatory Cytokines Elevated in Patients With Intercritical Gout, and Linked to MSU Deposition Size and CV Risk Factors
Researchers studied subclinical inflammation in intercritical gout and its association with the size of monosodium urate crystal deposition and cardiovascular risk factors.
Glecaprevir/Pibrentasvir Effective for Chronic HCV Infection With CKD
Glecaprevir/pibrentasvir for 8 to 12 weeks is an effective and well-tolerated treatment for patients with chronic hepatitis C virus and chronic kidney disease stage 4 or 5.
- Loading...
Loading...
Next post in Chronic Kidney Disease (CKD)
Loading... 
Loading...